Tomokazu Ohnuma
About
In The Last Decade
Tomokazu Ohnuma
22 papers receiving 539 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 317
- Pharmacology 212
- Oncology 145
- Genetics 93
- Organic Chemistry 71
Countries citing papers authored by Tomokazu Ohnuma
This map shows the geographic impact of Tomokazu Ohnuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomokazu Ohnuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomokazu Ohnuma more than expected).
Fields of papers citing papers by Tomokazu Ohnuma
This network shows the impact of papers produced by Tomokazu Ohnuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomokazu Ohnuma. The network helps show where Tomokazu Ohnuma may publish in the future.
Co-authorship network of co-authors of Tomokazu Ohnuma
This figure shows the co-authorship network connecting the top 25 collaborators of Tomokazu Ohnuma. A scholar is included among the top collaborators of Tomokazu Ohnuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomokazu Ohnuma. Tomokazu Ohnuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 18 | |
| 3 | 23 | |
| 4 | 0 | |
| 5 | 46 | |
| 6 | 34 | |
| 7 | 1 | |
| 8 | 57 | |
| 9 | 27 | |
| 10 | 24 | |
| 11 | 18 | |
| 12 | 42 | |
| 13 | 34 | |
| 14 | 47 | |
| 15 | 64 | |
| 16 | 86 | |
| 17 | N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate. | 2 |
| 18 | Schedule-dependent interaction of cytarabine plus doxorubicin or cytarabine plus mitoxantrone in acute myelocytic leukemia cells in culture. | 12 |
| 19 | Effects of anticancer agents on the shedding of cells from human multicellular tumor spheroids. | 6 |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.